More about
Meningococcus Serogroup B Disease
News
June 07, 2021
2 min read
Save
Pentavalent meningococcal vaccine shows promise in phase 2 trial
An investigational pentavalent vaccine for Neisseria meningitidis showed promise in a phase 2 trial conducted among toddlers in Mali, researchers reported in The New England Journal of Medicine.